NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine-1,1-dione
|
7-chloro-3-methyl-4H-1λ6,2,4-benzothiadiazine-1,1-dione
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Dizoxide
|
Eudemine
|
Hyperstat
|
Hypertonalum
|
Mutabase
|
Proglicem
|
Proglycem
|
|
|
Synonyms
|
Diazoxide
|
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-Dioxide
|
3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-Dioxide
|
Dizoxide
|
Hyperstat
|
Hypertonalum
|
Mutabase
|
NSC 64198
|
NSC 76130
|
Proglicem
|
Proglycem
|
SRG 95213
|
Sch 6783
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
10.483212
|
H Acceptors
|
4
|
H Donor
|
1
|
LogD (pH = 5.5)
|
1.0004389
|
LogD (pH = 7.4)
|
1.0001315
|
Log P
|
1.0004865
|
Molar Refractivity
|
54.8408 cm3
|
Polarizability
|
21.23918 Å3
|
Polar Surface Area
|
58.53 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.09
|
LOG S
|
-2.62
|
Solubility (Water)
|
5.52e-01 g/l
|
DETAILS
DETAILS
DrugBank
TRC
DrugBank -
DB01119
|
Item |
Information |
Drug Groups
|
approved |
Description
|
A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. [PubChem] |
Indication |
Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma. |
Pharmacology |
Diazoxide is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. This switches off voltage-gated calcium ion channels which inhibits the generation of an action potential. |
Toxicity |
Oral LD50 in rat and mouse: 980 mg/kg and 444 mg/kg, respectively. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic. |
Absorption |
Readily absorbed following oral administration. |
Half Life |
28 ±8.3 hours in normal adults. |
Protein Binding |
Very high (more than 90%) to serum proteins. |
Elimination |
Proglycem is extensively bound (more than 90%) to serum proteins, and is excreted in the kidneys. |
External Links |
|
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Baba, A., et al.: J. Neurosci., 23, 7737 (2003)
- • Bancila, V., et al.: J. Neurochem., 90, 1243 (2003)
- • Bancila, V., et al.: J. Biol. Chem., 280, 8793 (2003)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent